Simvastatin Drug Profile
What is Simvastatin?
Simvastatin is a prescription medication belonging to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in patients with elevated blood cholesterol or those at high risk for heart disease. Simvastatin works by blocking an enzyme in the liver that produces cholesterol, helping to decrease both total cholesterol and low-density lipoprotein (LDL) or “bad” cholesterol levels.
Uses
- High cholesterol (hypercholesterolemia): Reduces total cholesterol, LDL cholesterol, and triglycerides while increasing HDL (“good”) cholesterol
- Prevention of cardiovascular events: Decreases risk of heart attack, stroke, and need for heart procedures in high-risk patients
- Familial hypercholesterolemia: Treats inherited conditions causing severely elevated cholesterol levels
- Secondary prevention: Reduces risk of future cardiovascular events in patients with existing coronary heart disease
- Diabetes management: Helps reduce cardiovascular risk in diabetic patients with elevated cholesterol
How it works
Simvastatin blocks the action of HMG-CoA reductase, an enzyme that plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to manufacture cholesterol, forcing the body to remove cholesterol from the bloodstream to meet its needs. This mechanism effectively lowers blood cholesterol levels and may also have additional benefits for blood vessel health and inflammation reduction.
Side effects
Common side effects:
- Headache
- Muscle pain or weakness
- Nausea
- Stomach pain or cramping
- Constipation
- Upper respiratory infections
- Dizziness
- Fatigue
Serious side effects to watch for:
- Severe muscle pain, tenderness, or weakness (possible rhabdomyolysis)
- Dark-colored urine
- Yellowing of skin or eyes (liver problems)
- Persistent nausea or vomiting
- Memory problems or confusion
Warnings and precautions
- Liver disease: Should be avoided in patients with active liver disease or unexplained elevated liver enzymes; regular liver function monitoring may be required
- Muscle disorders: Risk of muscle damage increases with higher doses and certain drug combinations; patients should report unexplained muscle pain immediately
- Pregnancy and breastfeeding: Contraindicated during pregnancy and breastfeeding as cholesterol is essential for fetal development
- Kidney impairment: Dose adjustments may be necessary in patients with severe kidney disease
- Age considerations: Elderly patients may be more susceptible to muscle-related side effects and require lower starting doses
Interactions
- Warfarin and other blood thinners: May increase bleeding risk; requires close monitoring of clotting times
- Cyclosporine: Significantly increases simvastatin levels, raising risk of muscle damage
- Gemfibrozil and other fibrates: Increases risk of muscle toxicity when combined with statins
- Grapefruit juice: Can increase simvastatin levels and side effects; should be avoided or limited
- Amiodarone: Heart rhythm medication that can increase simvastatin concentration
- Niacin (high doses): May increase risk of muscle problems when combined with simvastatin
- Antifungal medications: Drugs like itraconazole and ketoconazole can increase simvastatin levels
- HIV protease inhibitors: Can significantly increase statin concentrations and toxicity risk
Check interactions with the GMJ Interaction Checker
Dosage
Typical adult dosages range from 5mg to 40mg taken once daily in the evening, as cholesterol production is highest at night. Most patients start with 10mg to 20mg daily, with dosage adjustments made every 4 weeks based on cholesterol levels and patient response. The maximum recommended dose is 40mg daily, as higher doses significantly increase the risk of muscle-related side effects. Patients with severe kidney disease or those taking certain interacting medications may require lower doses. Dosage should always be determined and monitored by a healthcare provider based on individual patient factors, cholesterol levels, and cardiovascular risk assessment.
Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.
Cite this page
GMJ News Desk. "Simvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/simvastatin-2/
This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).Was this article helpful?


